TCL Archive Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says By Cancer History Project November 28, 2014
TCL Archive Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm By Cancer History Project November 28, 2014
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies By Cancer History Project November 28, 2014
TCL Archive Galeterone Shows Potential In CRPC AR Variants, Study Says By Cancer History Project November 28, 2014
TCL Archive NCI CTEP-Approved Trials For the Month of November By Cancer History Project November 28, 2014
TCL Archive Cyramza Combination Approved In Advanced Gastric Cancer By Cancer History Project November 28, 2014
TCL Archive Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure By Cancer History Project November 26, 2014
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light By Cancer History Project November 26, 2014
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
